[The immunological and epidemiological characteristics of viral hepatitis E in servicemen]. 1994

P I Ogarkov, and N V Doroshenko, and V S Tokmakov

UI MeSH Term Description Entries
D008889 Military Personnel Persons including soldiers involved with the armed forces. Air Force Personnel,Armed Forces Personnel,Army Personnel,Coast Guard,Marines,Navy Personnel,Sailors,Soldiers,Submariners,Military,Force Personnel, Air,Personnel, Air Force,Personnel, Armed Forces,Personnel, Army,Personnel, Military,Personnel, Navy,Sailor,Soldier,Submariner
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological
D016751 Hepatitis E Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission. Enterically-Transmitted Non-A, Non-B Hepatitis,Epidemic Non-A, Non-B Hepatitis,Hepatitis, Viral, Non-A, Non-B, Enterically-Transmitted,Hepatitis, Water-Borne,ET-NANBH,Enterically Transmitted Non A, Non B Hepatitis,Epidemic Non A, Non B Hepatitis,Hepatitides, Water-Borne,Hepatitis, Water Borne,Water-Borne Hepatitides,Water-Borne Hepatitis

Related Publications

P I Ogarkov, and N V Doroshenko, and V S Tokmakov
June 1992, Voenno-meditsinskii zhurnal,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
January 1999, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
May 2011, Virology journal,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
November 2016, Pakistan journal of pharmaceutical sciences,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
July 1970, California medicine,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
August 1991, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
October 2014, Cold Spring Harbor perspectives in medicine,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
January 2009, Folia medica,
P I Ogarkov, and N V Doroshenko, and V S Tokmakov
January 1959, Acta microbiologica Academiae Scientiarum Hungaricae,
Copied contents to your clipboard!